id
stringlengths 11
11
| tags
stringlengths 10
777
| text
stringlengths 2
1.5k
| dataset_num
int64 1
3
| tokens
list | ner_tags
list |
|---|---|---|---|---|---|
NCT03050801
|
13:55:chronic_disease,85:91:chronic_disease,93:110:chronic_disease,112:129:chronic_disease,131:144:chronic_disease,148:164:chronic_disease
|
Any current major neurological or psychiatric disorder such as (but not limited to) stroke, Parkinson disease, Alzheimer disease, schizophrenia or major depression
| 1
|
[
"Any",
"current",
"major",
"neurological",
"or",
"psychiatric",
"disorder",
"such",
"as",
"(",
"but",
"not",
"limited",
"to",
")",
"stroke",
",",
"Parkinson",
"disease",
",",
"Alzheimer",
"disease",
",",
"schizophrenia",
"or",
"major",
"depression"
] |
[
0,
0,
2,
2,
2,
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
2,
0,
2,
2,
0,
2,
2,
0,
2,
0,
0,
0
] |
NCT02607748
|
1:54:chronic_disease
|
Multiple premature ventricular or atrial contractions
| 1
|
[
"Multiple",
"premature",
"ventricular",
"or",
"atrial",
"contractions"
] |
[
2,
2,
2,
2,
2,
2
] |
NCT02207439
|
10:17:treatment,25:59:chronic_disease,60:78:treatment
|
Previous therapy with a human immunodeficiency virus (HIV) protease inhibitor
| 1
|
[
"Previous",
"therapy",
"with",
"a",
"human",
"immunodeficiency",
"virus",
"(",
"HIV",
")",
"protease",
"inhibitor"
] |
[
0,
1,
0,
0,
2,
2,
2,
2,
0,
0,
1,
1
] |
NCT03082612
|
42:54:treatment
|
Have completed surgery with no plans for chemotherapy
| 1
|
[
"Have",
"completed",
"surgery",
"with",
"no",
"plans",
"for",
"chemotherapy"
] |
[
0,
0,
0,
0,
0,
0,
0,
1
] |
NCT02250534
|
40:63:chronic_disease
|
without current (within the past year) serious mental disorder
| 1
|
[
"without",
"current",
"(",
"within",
"the",
"past",
"year",
")",
"serious",
"mental",
"disorder"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
2,
2,
2
] |
NCT01174108
|
1:23:chronic_disease,27:35:chronic_disease,65:76:treatment,95:106:chronic_disease
|
Refractory anemia (RA) or RARS MDS patients who have associated transfusion dependence and/or neutropenia
| 1
|
[
"Refractory",
"anemia",
"(",
"RA",
")",
"or",
"RARS",
"MDS",
"patients",
"who",
"have",
"associated",
"transfusion",
"dependence",
"and/or",
"neutropenia"
] |
[
2,
2,
2,
0,
0,
0,
2,
2,
0,
0,
0,
0,
1,
0,
0,
2
] |
NCT01698658
|
15:24:treatment,26:43:treatment,51:61:treatment
|
Scheduled for mammogram, breast ultrasound and/or breast MRI
| 1
|
[
"Scheduled",
"for",
"mammogram",
",",
"breast",
"ultrasound",
"and/or",
"breast",
"MRI"
] |
[
0,
0,
1,
0,
1,
1,
0,
0,
0
] |
NCT02304458
|
47:63:treatment
|
Parts C, D, and E: patients who have received prior ipilimumab
| 1
|
[
"Parts",
"C",
",",
"D",
",",
"and",
"E",
":",
"patients",
"who",
"have",
"received",
"prior",
"ipilimumab"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
1
] |
NCT02204098
|
1:17:treatment
|
Hormonal therapy
| 1
|
[
"Hormonal",
"therapy"
] |
[
1,
1
] |
NCT02565901
|
4:18:cancer
|
In situ carcinoma of any site
| 1
|
[
"In",
"situ",
"carcinoma",
"of",
"any",
"site"
] |
[
0,
3,
3,
0,
0,
0
] |
NCT03119363
|
1:74:treatment
|
Previous use of light therapy to alleviate fatigue or depressive symptoms
| 1
|
[
"Previous",
"use",
"of",
"light",
"therapy",
"to",
"alleviate",
"fatigue",
"or",
"depressive",
"symptoms"
] |
[
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1
] |
NCT02709980
|
,61:64:chronic_disease
|
Report sleep problems for >1 month that developed after the TBI
| 1
|
[
"Report",
"sleep",
"problems",
"for",
">",
"1",
"month",
"that",
"developed",
"after",
"the",
"TBI"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
2
] |
NCT02124772
|
15:28:cancer,54:75:treatment,75:81:treatment,94:111:treatment,114:135:treatment
|
Subjects with neuroblastoma that is only detected by bone marrow aspirate/biopsy or elevated homovanillic acid / vanillylmandelic acid (HVA/VMA)
| 1
|
[
"Subjects",
"with",
"neuroblastoma",
"that",
"is",
"only",
"detected",
"by",
"bone",
"marrow",
"aspirate/biopsy",
"or",
"elevated",
"homovanillic",
"acid",
"/",
"vanillylmandelic",
"acid",
"(",
"HVA/VMA",
")"
] |
[
0,
0,
3,
0,
0,
0,
0,
0,
1,
1,
1,
0,
0,
1,
1,
0,
1,
1,
0,
0,
0
] |
NCT01943851
|
,48:58:treatment
|
At least 3 months has elapsed from the time of transplant
| 1
|
[
"At",
"least",
"3",
"months",
"has",
"elapsed",
"from",
"the",
"time",
"of",
"transplant"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1
] |
NCT01871766
|
,189:201:treatment
|
Participants treated on this protocol in the low or intermediate risk arm who experience disease progression prior to week 13 will transfer to the high risk arm and proceed with high risk chemotherapy starting at week 1 of the protocol
| 1
|
[
"Participants",
"treated",
"on",
"this",
"protocol",
"in",
"the",
"low",
"or",
"intermediate",
"risk",
"arm",
"who",
"experience",
"disease",
"progression",
"prior",
"to",
"week",
"13",
"will",
"transfer",
"to",
"the",
"high",
"risk",
"arm",
"and",
"proceed",
"with",
"high",
"risk",
"chemotherapy",
"starting",
"at",
"week",
"1",
"of",
"the",
"protocol"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0,
0,
0,
0,
0,
0,
0
] |
NCT03096418
|
177:190:cancer
|
studies (window studies, for example) that are deemed non-therapeutic, including those that utilize agents that are not FDA approved for the treatment of the patient's current breast cancer, are permitted
| 1
|
[
"studies",
"(",
"window",
"studies",
",",
"for",
"example",
")",
"that",
"are",
"deemed",
"non-therapeutic",
",",
"including",
"those",
"that",
"utilize",
"agents",
"that",
"are",
"not",
"FDA",
"approved",
"for",
"the",
"treatment",
"of",
"the",
"patient",
"'s",
"current",
"breast",
"cancer",
",",
"are",
"permitted"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
3,
3,
0,
0,
0
] |
NCT02982564
|
16:29:cancer
|
Diagnosed with breast cancer
| 1
|
[
"Diagnosed",
"with",
"breast",
"cancer"
] |
[
0,
0,
3,
3
] |
NCT02412540
|
,,42:54:treatment,
|
Weight reduction of >5% between baseline liver biopsy and enrollment, as weight loss >5% may change NASH severity
| 1
|
[
"Weight",
"reduction",
"of",
">",
"5",
"%",
"between",
"baseline",
"liver",
"biopsy",
"and",
"enrollment",
",",
"as",
"weight",
"loss",
">",
"5",
"%",
"may",
"change",
"NASH",
"severity"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02343549
|
18:39:treatment,41:86:treatment,91:122:treatment
|
Currently taking cytotoxic medications, non-steroidal ant-inflammatory drugs (NSAIDS), or enzyme inducing anticonvulsants
| 1
|
[
"Currently",
"taking",
"cytotoxic",
"medications",
",",
"non-steroidal",
"ant-inflammatory",
"drugs",
"(",
"NSAIDS",
")",
",",
"or",
"enzyme",
"inducing",
"anticonvulsants"
] |
[
0,
0,
1,
1,
0,
1,
1,
1,
1,
0,
0,
0,
0,
1,
1,
1
] |
NCT02715583
|
12:18:treatment,51:85:cancer,95:113:cancer
|
History of biopsy proven or clinically documented castrate resistant prostate cancer which is metastatic to bone as assessed by medical record review
| 1
|
[
"History",
"of",
"biopsy",
"proven",
"or",
"clinically",
"documented",
"castrate",
"resistant",
"prostate",
"cancer",
"which",
"is",
"metastatic",
"to",
"bone",
"as",
"assessed",
"by",
"medical",
"record",
"review"
] |
[
0,
0,
1,
0,
0,
0,
0,
3,
3,
3,
3,
0,
0,
3,
3,
3,
0,
0,
0,
0,
0,
0
] |
NCT02061293
|
12:24:treatment,,
|
History of hallucinogen use disorder, or any use in the past 1 year, or >25 lifetime uses
| 1
|
[
"History",
"of",
"hallucinogen",
"use",
"disorder",
",",
"or",
"any",
"use",
"in",
"the",
"past",
"1",
"year",
",",
"or",
">",
"25",
"lifetime",
"uses"
] |
[
0,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02426476
|
14:21:chronic_disease,23:32:chronic_disease,34:39:chronic_disease,43:72:chronic_disease,80:90:chronic_disease
|
a history of bipolar, psychotic, panic or obsessive-compulsive disorder (note: depression is an exclusion)
| 1
|
[
"a",
"history",
"of",
"bipolar",
",",
"psychotic",
",",
"panic",
"or",
"obsessive-compulsive",
"disorder",
"(",
"note",
":",
"depression",
"is",
"an",
"exclusion",
")"
] |
[
0,
0,
0,
2,
0,
2,
0,
2,
0,
2,
2,
0,
0,
0,
2,
0,
0,
0,
0
] |
NCT02438995
|
1:6:cancer
|
Tumor Recurrence which is surgically unresectable
| 1
|
[
"Tumor",
"Recurrence",
"which",
"is",
"surgically",
"unresectable"
] |
[
3,
0,
0,
0,
0,
0
] |
NCT02243631
|
13:30:chronic_disease,,
|
Significant renal dysfunction (CKD >stage 2)
| 1
|
[
"Significant",
"renal",
"dysfunction",
"(",
"CKD",
">",
"stage",
"2",
")"
] |
[
0,
2,
2,
0,
0,
0,
0,
0,
0
] |
NCT02762006
|
25:53:treatment,,94:104:treatment,144:167:treatment,152:166:treatment,171:195:treatment,,257:267:treatment
|
Current or prior use of immunosuppressive medication within 28 days before the first dose of durvalumab, with the exceptions of intranasal and inhaled corticosteroids or systemic corticosteroids at physiological doses, which are not to exceed 10 mg/day of prednisone, or an equivalent corticosteroid
| 1
|
[
"Current",
"or",
"prior",
"use",
"of",
"immunosuppressive",
"medication",
"within",
"28",
"days",
"before",
"the",
"first",
"dose",
"of",
"durvalumab",
",",
"with",
"the",
"exceptions",
"of",
"intranasal",
"and",
"inhaled",
"corticosteroids",
"or",
"systemic",
"corticosteroids",
"at",
"physiological",
"doses",
",",
"which",
"are",
"not",
"to",
"exceed",
"10",
"mg/day",
"of",
"prednisone",
",",
"or",
"an",
"equivalent",
"corticosteroid"
] |
[
0,
0,
0,
0,
0,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0,
0,
0,
0,
0,
0,
0,
1,
1,
0,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0,
0,
0,
0,
1
] |
NCT02593526
|
30:39:treatment
|
History of poor adherence to treatment
| 1
|
[
"History",
"of",
"poor",
"adherence",
"to",
"treatment"
] |
[
0,
0,
0,
0,
0,
1
] |
NCT02593123
|
1:35:treatment,
|
previous treatment with equine ATG is allowed if more than 3 months ago
| 1
|
[
"previous",
"treatment",
"with",
"equine",
"ATG",
"is",
"allowed",
"if",
"more",
"than",
"3",
"months",
"ago"
] |
[
1,
1,
1,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02624518
|
1:32:treatment
|
Post radical prostatectomy (RP)
| 1
|
[
"Post",
"radical",
"prostatectomy",
"(",
"RP",
")"
] |
[
1,
1,
1,
1,
0,
0
] |
NCT02784535
|
1:10:chronic_disease
|
urticaria
| 1
|
[
"urticaria"
] |
[
2
] |
NCT02346929
|
1:21:chronic_disease
|
High acuity/distress per the Attending ED physician
| 1
|
[
"High",
"acuity/distress",
"per",
"the",
"Attending",
"ED",
"physician"
] |
[
2,
2,
0,
0,
0,
0,
0
] |
NCT01581749
|
15:34:cancer,52:67:cancer,71:101:cancer,
|
history of an invasive malignancy (other than this prostate cancer,or basal or squamous skin cancers) within prior 5 years
| 1
|
[
"history",
"of",
"an",
"invasive",
"malignancy",
"(",
"other",
"than",
"this",
"prostate",
"cancer",
",",
"or",
"basal",
"or",
"squamous",
"skin",
"cancers",
")",
"within",
"prior",
"5",
"years"
] |
[
0,
0,
0,
3,
3,
0,
0,
0,
0,
3,
3,
0,
0,
3,
3,
3,
3,
3,
0,
0,
0,
0,
0
] |
NCT02089607
|
40:54:treatment
|
A sealing zone in the target aorta (or surgical graft) that is proximal to the primary dissection, such that a stent-graft would be anticipated to seal off the dissection lumen
| 1
|
[
"A",
"sealing",
"zone",
"in",
"the",
"target",
"aorta",
"(",
"or",
"surgical",
"graft",
")",
"that",
"is",
"proximal",
"to",
"the",
"primary",
"dissection",
",",
"such",
"that",
"a",
"stent-graft",
"would",
"be",
"anticipated",
"to",
"seal",
"off",
"the",
"dissection",
"lumen"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT03014687
|
1:17:chronic_disease
|
Immunodeficiency
| 1
|
[
"Immunodeficiency"
] |
[
2
] |
NCT02862210
|
8:33:treatment
|
Use of antipsychotic medications
| 1
|
[
"Use",
"of",
"antipsychotic",
"medications"
] |
[
0,
0,
1,
1
] |
NCT02772562
|
1:13:chronic_disease,17:42:chronic_disease,51:57:chronic_disease,59:68:chronic_disease
|
Inflammatory or exfoliative skin diseases such as eczema, psoriasis that disrupt epidermis
| 1
|
[
"Inflammatory",
"or",
"exfoliative",
"skin",
"diseases",
"such",
"as",
"eczema",
",",
"psoriasis",
"that",
"disrupt",
"epidermis"
] |
[
2,
0,
2,
2,
2,
0,
0,
2,
0,
2,
0,
0,
0
] |
NCT02303977
|
,41:53:treatment
|
Pregnant or breast-feeding patients, as chemotherapy is thought to present substantial risk to the fetus/infant
| 1
|
[
"Pregnant",
"or",
"breast-feeding",
"patients",
",",
"as",
"chemotherapy",
"is",
"thought",
"to",
"present",
"substantial",
"risk",
"to",
"the",
"fetus/infant"
] |
[
0,
0,
0,
0,
0,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02339922
|
18:26:allergy_name
|
Known allergy to ixazomib, its analogues, or excipients in the various formulations of ixazomib
| 1
|
[
"Known",
"allergy",
"to",
"ixazomib",
",",
"its",
"analogues",
",",
"or",
"excipients",
"in",
"the",
"various",
"formulations",
"of",
"ixazomib"
] |
[
0,
0,
0,
4,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT03136029
|
1:21:cancer
|
End-stage Malignancy
| 1
|
[
"End-stage",
"Malignancy"
] |
[
3,
3
] |
NCT02658565
|
23:35:treatment
|
Patients who received chemotherapy directed at the present disease
| 1
|
[
"Patients",
"who",
"received",
"chemotherapy",
"directed",
"at",
"the",
"present",
"disease"
] |
[
0,
0,
0,
1,
0,
0,
0,
0,
0
] |
NCT02424968
|
,171:210:treatment
|
Must be in a state of general good health and have completed a donor evaluation with history, medical examination and standard blood tests within 35 days of starting the hematopoietic cell collection procedure
| 1
|
[
"Must",
"be",
"in",
"a",
"state",
"of",
"general",
"good",
"health",
"and",
"have",
"completed",
"a",
"donor",
"evaluation",
"with",
"history",
",",
"medical",
"examination",
"and",
"standard",
"blood",
"tests",
"within",
"35",
"days",
"of",
"starting",
"the",
"hematopoietic",
"cell",
"collection",
"procedure"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
1,
1,
1
] |
NCT01695967
|
1:39:chronic_disease
|
congenital head and neck malformations
| 1
|
[
"congenital",
"head",
"and",
"neck",
"malformations"
] |
[
2,
2,
2,
2,
2
] |
NCT02473276
|
84:122:treatment,143:163:treatment,167:184:treatment
|
who are known to have had accidental dural puncture with an epidural needle during placement of neuraxial labor analgesia, and have either an intrathecal catheter or epidural catheter in place
| 1
|
[
"who",
"are",
"known",
"to",
"have",
"had",
"accidental",
"dural",
"puncture",
"with",
"an",
"epidural",
"needle",
"during",
"placement",
"of",
"neuraxial",
"labor",
"analgesia",
",",
"and",
"have",
"either",
"an",
"intrathecal",
"catheter",
"or",
"epidural",
"catheter",
"in",
"place"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
1,
0,
1,
1,
1,
1,
1,
0,
0,
0,
0,
0,
1,
1,
0,
0,
0,
0,
0
] |
NCT02584647
|
10:15:cancer,,,25:50:treatment,55:73:treatment
|
Phase 2: MPNST with 0-3 prior systemic treatments (no prior radiotherapy is necessary)
| 1
|
[
"Phase",
"2",
":",
"MPNST",
"with",
"0-3",
"prior",
"systemic",
"treatments",
"(",
"no",
"prior",
"radiotherapy",
"is",
"necessary",
")"
] |
[
0,
0,
0,
3,
0,
0,
1,
1,
1,
0,
0,
0,
0,
0,
0,
0
] |
NCT01943851
|
1:12:treatment,17:38:cancer,40:55:treatment
|
Hydroxyurea for proliferative disease, Corticosteroids, Use of hematopoetic growth factors is permitted at the discretion of the investigator according to published guidelines (e.g., National Comprehensive Cancer Network (NCCN), American Society of Clinical Oncology (ASCO), American Society of Hematology (ASH), etc.)
| 1
|
[
"Hydroxyurea",
"for",
"proliferative",
"disease",
",",
"Corticosteroids",
",",
"Use",
"of",
"hematopoetic",
"growth",
"factors",
"is",
"permitted",
"at",
"the",
"discretion",
"of",
"the",
"investigator",
"according",
"to",
"published",
"guidelines",
"(",
"e.g.",
",",
"National",
"Comprehensive",
"Cancer",
"Network",
"(",
"NCCN",
")",
",",
"American",
"Society",
"of",
"Clinical",
"Oncology",
"(",
"ASCO",
")",
",",
"American",
"Society",
"of",
"Hematology",
"(",
"ASH",
")",
",",
"etc",
".",
")"
] |
[
1,
0,
3,
3,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02201992
|
31:34:treatment
|
Patient registered to and the ALK fusion status performed centrally on the ALCHEMIST-SCREEN (ALLIANCE A151216)
| 1
|
[
"Patient",
"registered",
"to",
"and",
"the",
"ALK",
"fusion",
"status",
"performed",
"centrally",
"on",
"the",
"ALCHEMIST-SCREEN",
"(",
"ALLIANCE",
"A151216",
")"
] |
[
0,
0,
0,
0,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02259621
|
12:23:treatment
|
Diagnostic core biopsy specimens must be reviewed by a faculty pathologist at SKCCC or MSKCC
| 1
|
[
"Diagnostic",
"core",
"biopsy",
"specimens",
"must",
"be",
"reviewed",
"by",
"a",
"faculty",
"pathologist",
"at",
"SKCCC",
"or",
"MSKCC"
] |
[
0,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02053246
|
32:62:chronic_disease,,,,
|
with World Health Organization Group 2 Pulmonary Hypertension (Mean pulmonary artery pressure ≥ 25 mmHg and pulmonary capillary wedge pressure ≥ 15 mmHg)
| 1
|
[
"with",
"World",
"Health",
"Organization",
"Group",
"2",
"Pulmonary",
"Hypertension",
"(",
"Mean",
"pulmonary",
"artery",
"pressure",
"≥",
"25",
"mmHg",
"and",
"pulmonary",
"capillary",
"wedge",
"pressure",
"≥",
"15",
"mmHg",
")"
] |
[
0,
0,
0,
0,
2,
2,
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02405078
|
16:65:treatment,
|
Negative serum beta-human chorionic gonadotropin (beta-hCG) test (women of childbearing potential only)
| 1
|
[
"Negative",
"serum",
"beta-human",
"chorionic",
"gonadotropin",
"(",
"beta-hCG",
")",
"test",
"(",
"women",
"of",
"childbearing",
"potential",
"only",
")"
] |
[
0,
0,
1,
1,
1,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02357849
|
26:51:chronic_disease,64:89:chronic_disease,91:104:chronic_disease,106:130:chronic_disease,132:148:chronic_disease,153:169:chronic_disease
|
lifetime diagnosis of an Axis I psychotic disorder, including: schizophreniform disorder, schizophrenia, schizoaffective disorder, bipolar disorder, or major depression with psychotic features
| 1
|
[
"lifetime",
"diagnosis",
"of",
"an",
"Axis",
"I",
"psychotic",
"disorder",
",",
"including",
":",
"schizophreniform",
"disorder",
",",
"schizophrenia",
",",
"schizoaffective",
"disorder",
",",
"bipolar",
"disorder",
",",
"or",
"major",
"depression",
"with",
"psychotic",
"features"
] |
[
0,
0,
0,
0,
2,
2,
2,
2,
0,
0,
0,
2,
2,
0,
2,
0,
2,
2,
0,
2,
2,
0,
0,
2,
2,
0,
0,
0
] |
NCT02427841
|
,,,,156:168:treatment,,,
|
Women of child-bearing potential and men must be willing to use adequate contraception during the entire study and for 8 weeks following completion of all chemotherapy on study; this includes hormonal or barrier method, or abstinence
| 1
|
[
"Women",
"of",
"child-bearing",
"potential",
"and",
"men",
"must",
"be",
"willing",
"to",
"use",
"adequate",
"contraception",
"during",
"the",
"entire",
"study",
"and",
"for",
"8",
"weeks",
"following",
"completion",
"of",
"all",
"chemotherapy",
"on",
"study",
";",
"this",
"includes",
"hormonal",
"or",
"barrier",
"method",
",",
"or",
"abstinence"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02452008
|
5:14:treatment,16:26:treatment,37:67:treatment,,110:120:treatment
|
Had radiation, biological, or other investigational cancer therapy within 2 weeks prior to the first dose of study drug
| 1
|
[
"Had",
"radiation",
",",
"biological",
",",
"or",
"other",
"investigational",
"cancer",
"therapy",
"within",
"2",
"weeks",
"prior",
"to",
"the",
"first",
"dose",
"of",
"study",
"drug"
] |
[
0,
1,
0,
1,
0,
0,
0,
1,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
1
] |
NCT03091790
|
28:49:treatment
|
Patient scheduled for open ventral hernia repair at LBJ General Hospital
| 1
|
[
"Patient",
"scheduled",
"for",
"open",
"ventral",
"hernia",
"repair",
"at",
"LBJ",
"General",
"Hospital"
] |
[
0,
0,
0,
0,
1,
1,
1,
0,
0,
0,
0
] |
NCT02204098
|
1:8:treatment
|
Surgery
| 1
|
[
"Surgery"
] |
[
1
] |
NCT01620216
|
105:117:treatment
|
certain agents that prolong the corrected QT interval may be allowed but only after discussion with the chemotherapy pharmacist
| 1
|
[
"certain",
"agents",
"that",
"prolong",
"the",
"corrected",
"QT",
"interval",
"may",
"be",
"allowed",
"but",
"only",
"after",
"discussion",
"with",
"the",
"chemotherapy",
"pharmacist"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0
] |
NCT02418195
|
1:18:chronic_disease
|
Myasthenia gravis
| 1
|
[
"Myasthenia",
"gravis"
] |
[
2,
2
] |
NCT02725567
|
57:81:treatment,
|
Use of any moderate or strong inducers or inhibitors of cytochrome P450 (CYP) 3A within 2 weeks before Day 1
| 1
|
[
"Use",
"of",
"any",
"moderate",
"or",
"strong",
"inducers",
"or",
"inhibitors",
"of",
"cytochrome",
"P450",
"(",
"CYP",
")",
"3A",
"within",
"2",
"weeks",
"before",
"Day",
"1"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
1,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02549937
|
21:36:cancer,60:70:treatment,72:81:treatment
|
locally advanced or metastatic pNET that has progressed on everolimus, sunitinib or both, during the expansion phase
| 1
|
[
"locally",
"advanced",
"or",
"metastatic",
"pNET",
"that",
"has",
"progressed",
"on",
"everolimus",
",",
"sunitinib",
"or",
"both",
",",
"during",
"the",
"expansion",
"phase"
] |
[
0,
0,
0,
3,
3,
0,
0,
0,
0,
1,
0,
1,
0,
0,
0,
0,
0,
0,
0
] |
NCT02848417
|
1:10:chronic_disease
|
Dementias of any type
| 1
|
[
"Dementias",
"of",
"any",
"type"
] |
[
2,
0,
0,
0
] |
NCT03179163
|
1:9:chronic_disease
|
diabetes
| 1
|
[
"diabetes"
] |
[
2
] |
NCT02579967
|
,,,75:99:treatment,94:98:treatment,103:107:treatment,,,209:212:treatment,214:217:treatment,222:229:treatment,,413:416:treatment
|
Left ventricular ejection fraction (LVEF) greater than or equal to 40% by 2D echocardiogram (ECHO) or MUGA, or left ventricular shortening fraction greater than or equal to 20% by ECHO for patients receiving MAC, RIC, or RIC-MMF, or LVEF greater than or equal to 30% if the patient has radiologic evidence of aortic, renal, or coronary artery vasculitis. LVEF greater than or equal to 30% for patients receiving IOC
| 1
|
[
"Left",
"ventricular",
"ejection",
"fraction",
"(",
"LVEF",
")",
"greater",
"than",
"or",
"equal",
"to",
"40",
"%",
"by",
"2D",
"echocardiogram",
"(",
"ECHO",
")",
"or",
"MUGA",
",",
"or",
"left",
"ventricular",
"shortening",
"fraction",
"greater",
"than",
"or",
"equal",
"to",
"20",
"%",
"by",
"ECHO",
"for",
"patients",
"receiving",
"MAC",
",",
"RIC",
",",
"or",
"RIC-MMF",
",",
"or",
"LVEF",
"greater",
"than",
"or",
"equal",
"to",
"30",
"%",
"if",
"the",
"patient",
"has",
"radiologic",
"evidence",
"of",
"aortic",
",",
"renal",
",",
"or",
"coronary",
"artery",
"vasculitis",
".",
"LVEF",
"greater",
"than",
"or",
"equal",
"to",
"30",
"%",
"for",
"patients",
"receiving",
"IOC"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
1,
1,
1,
0,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0,
1,
0,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1
] |
NCT02551679
|
14:24:cancer
|
Diagnosis of malignancy
| 1
|
[
"Diagnosis",
"of",
"malignancy"
] |
[
0,
0,
3
] |
NCT01239160
|
21:111:cancer
|
have a diagnosis of primary or secondary late Stage 2 or 3 unilateral or bilateral lower extremity lymphoedema
| 1
|
[
"have",
"a",
"diagnosis",
"of",
"primary",
"or",
"secondary",
"late",
"Stage",
"2",
"or",
"3",
"unilateral",
"or",
"bilateral",
"lower",
"extremity",
"lymphoedema"
] |
[
0,
0,
0,
0,
3,
3,
3,
3,
3,
3,
3,
3,
3,
3,
3,
3,
3,
3
] |
NCT02446457
|
,,,55:64:treatment
|
Platelets >= 75 x 10^9/L, performed within 28 days of treatment initiation
| 1
|
[
"Platelets",
">",
"=",
"75",
"x",
"10^9/L",
",",
"performed",
"within",
"28",
"days",
"of",
"treatment",
"initiation"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0
] |
NCT02513485
|
61:69:treatment
|
Substance dependence [or abuse within the past year (except nicotine)], unless otherwise approved by the PI or PI's designee
| 1
|
[
"Substance",
"dependence",
"[",
"or",
"abuse",
"within",
"the",
"past",
"year",
"(",
"except",
"nicotine",
")",
"]",
",",
"unless",
"otherwise",
"approved",
"by",
"the",
"PI",
"or",
"PI",
"'s",
"designee"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT01660607
|
1:4:chronic_disease
|
HIV ab
| 1
|
[
"HIV",
"ab"
] |
[
2,
0
] |
NCT02744391
|
56:59:chronic_disease,61:70:chronic_disease,75:89:chronic_disease,97:122:treatment,126:139:treatment
|
Prefer not to be treated with a standard treatment for MDD, Dysthymia, or Depression NOS (e.g., antidepressant medication or psychotherapy)
| 1
|
[
"Prefer",
"not",
"to",
"be",
"treated",
"with",
"a",
"standard",
"treatment",
"for",
"MDD",
",",
"Dysthymia",
",",
"or",
"Depression",
"NOS",
"(",
"e.g.",
",",
"antidepressant",
"medication",
"or",
"psychotherapy",
")"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
2,
0,
2,
0,
0,
2,
2,
0,
0,
0,
1,
1,
0,
1,
0
] |
NCT02995733
|
,,,147:170:treatment
|
Participant must also have an ACT score of 19 or less, or a history of one or more exacerbations in the past year that required patient report of systemic corticosteroid use
| 1
|
[
"Participant",
"must",
"also",
"have",
"an",
"ACT",
"score",
"of",
"19",
"or",
"less",
",",
"or",
"a",
"history",
"of",
"one",
"or",
"more",
"exacerbations",
"in",
"the",
"past",
"year",
"that",
"required",
"patient",
"report",
"of",
"systemic",
"corticosteroid",
"use"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
1,
0
] |
NCT03127722
|
15:37:cancer
|
Subjects with gynecologic malignancy
| 1
|
[
"Subjects",
"with",
"gynecologic",
"malignancy"
] |
[
0,
0,
3,
3
] |
NCT02053766
|
32:55:treatment,59:80:treatment,116:134:treatment,
|
Subject is scheduled to have a non-emergent diagnostic or therapeutic procedure for routine medical care requiring general anesthesia estimated to last at least one hour
| 1
|
[
"Subject",
"is",
"scheduled",
"to",
"have",
"a",
"non-emergent",
"diagnostic",
"or",
"therapeutic",
"procedure",
"for",
"routine",
"medical",
"care",
"requiring",
"general",
"anesthesia",
"estimated",
"to",
"last",
"at",
"least",
"one",
"hour"
] |
[
0,
0,
0,
0,
0,
0,
1,
1,
0,
1,
1,
0,
0,
0,
0,
0,
1,
1,
0,
0,
0,
0,
0,
0,
0
] |
NCT03042689
|
1:36:chronic_disease
|
noninvasive aerodigestive neoplasms
| 1
|
[
"noninvasive",
"aerodigestive",
"neoplasms"
] |
[
2,
2,
2
] |
NCT02394535
|
30:42:chronic_disease,,
|
Known, existing uncontrolled coagulopathy, international normalized ratio (INR) > 1.5
| 1
|
[
"Known",
",",
"existing",
"uncontrolled",
"coagulopathy",
",",
"international",
"normalized",
"ratio",
"(",
"INR",
")",
">",
"1.5"
] |
[
0,
0,
0,
0,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02753283
|
20:27:treatment,39:53:treatment,55:64:treatment,69:81:treatment,,,173:188:treatment
|
Those currently on therapy (including bisphosphonate, denosumab, or teriparatide) or who have been on a bisphosphonate for > 1year during the previous 2 years because some bisphosphonates are long acting
| 1
|
[
"Those",
"currently",
"on",
"therapy",
"(",
"including",
"bisphosphonate",
",",
"denosumab",
",",
"or",
"teriparatide",
")",
"or",
"who",
"have",
"been",
"on",
"a",
"bisphosphonate",
"for",
">",
"1year",
"during",
"the",
"previous",
"2",
"years",
"because",
"some",
"bisphosphonates",
"are",
"long",
"acting"
] |
[
0,
0,
0,
1,
0,
0,
1,
0,
1,
0,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0,
0,
0
] |
NCT02400255
|
25:62:cancer
|
Active and/or untreated central nervous system (CNS) leukemia
| 1
|
[
"Active",
"and/or",
"untreated",
"central",
"nervous",
"system",
"(",
"CNS",
")",
"leukemia"
] |
[
0,
0,
0,
3,
3,
3,
3,
3,
0,
0
] |
NCT01895777
|
1:29:treatment
|
unfractionated heparin (UFH)
| 1
|
[
"unfractionated",
"heparin",
"(",
"UFH",
")"
] |
[
1,
1,
1,
0,
0
] |
NCT02239913
|
64:87:chronic_disease,101:138:chronic_disease,151:158:chronic_disease,199:219:chronic_disease
|
History of serious physical disease, current physical disease, impaired cardiovascular functioning, chronic obstructive pulmonary disease, history of seizure or current or past histories of serious psychiatric disorder that in the opinion of the study physician would interfere with study
| 1
|
[
"History",
"of",
"serious",
"physical",
"disease",
",",
"current",
"physical",
"disease",
",",
"impaired",
"cardiovascular",
"functioning",
",",
"chronic",
"obstructive",
"pulmonary",
"disease",
",",
"history",
"of",
"seizure",
"or",
"current",
"or",
"past",
"histories",
"of",
"serious",
"psychiatric",
"disorder",
"that",
"in",
"the",
"opinion",
"of",
"the",
"study",
"physician",
"would",
"interfere",
"with",
"study"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
2,
2,
0,
0,
2,
2,
2,
2,
0,
0,
0,
2,
0,
0,
0,
0,
0,
0,
0,
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT00368355
|
17:33:chronic_disease,93:114:treatment,129:144:treatment
|
Patients with a severe infection that on evaluation by the Principal Investigator precludes ablative chemotherapy or successful transplantation
| 1
|
[
"Patients",
"with",
"a",
"severe",
"infection",
"that",
"on",
"evaluation",
"by",
"the",
"Principal",
"Investigator",
"precludes",
"ablative",
"chemotherapy",
"or",
"successful",
"transplantation"
] |
[
0,
0,
0,
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
1,
1,
0,
0,
1
] |
NCT00788164
|
4:7:chronic_disease
|
No HIV seropositivity
| 1
|
[
"No",
"HIV",
"seropositivity"
] |
[
0,
2,
0
] |
NCT02710396
|
24:58:chronic_disease
|
Has a known history of Human Immunodeficiency Virus (HIV) (HIV 1/2 antibodies)
| 1
|
[
"Has",
"a",
"known",
"history",
"of",
"Human",
"Immunodeficiency",
"Virus",
"(",
"HIV",
")",
"(",
"HIV",
"1/2",
"antibodies",
")"
] |
[
0,
0,
0,
0,
0,
2,
2,
2,
2,
0,
0,
0,
0,
0,
0,
0
] |
NCT00930228
|
,81:97:chronic_disease
|
Controls will be healthy women with regular menstrual cycles and no evidence of hyperandrogenism
| 1
|
[
"Controls",
"will",
"be",
"healthy",
"women",
"with",
"regular",
"menstrual",
"cycles",
"and",
"no",
"evidence",
"of",
"hyperandrogenism"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
2
] |
NCT03098082
|
8:12:treatment,
|
Recent ERCP (i.e. within 1 month)
| 1
|
[
"Recent",
"ERCP",
"(",
"i.e",
".",
"within",
"1",
"month",
")"
] |
[
0,
1,
0,
0,
0,
0,
0,
0,
0
] |
NCT02166905
|
,,118:127:treatment
|
Patients of child-bearing potential must agree to use acceptable contraceptive methods (e.g., double barrier) during treatment
| 1
|
[
"Patients",
"of",
"child-bearing",
"potential",
"must",
"agree",
"to",
"use",
"acceptable",
"contraceptive",
"methods",
"(",
"e.g.",
",",
"double",
"barrier",
")",
"during",
"treatment"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1
] |
NCT02573493
|
,,,,,,,237:246:treatment
|
Women of childbearing potential and men must agree to use adequate contraception (hormonal or barrier method of birth control, abstinence) prior to study entry, for the duration of study participation, and for 3 months after completing treatment
| 1
|
[
"Women",
"of",
"childbearing",
"potential",
"and",
"men",
"must",
"agree",
"to",
"use",
"adequate",
"contraception",
"(",
"hormonal",
"or",
"barrier",
"method",
"of",
"birth",
"control",
",",
"abstinence",
")",
"prior",
"to",
"study",
"entry",
",",
"for",
"the",
"duration",
"of",
"study",
"participation",
",",
"and",
"for",
"3",
"months",
"after",
"completing",
"treatment"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1
] |
NCT02146924
|
39:52:treatment,
|
Non-hematological toxicity related to prior therapy must either have returned to =< grade 3, baseline, or deemed irreversible
| 1
|
[
"Non-hematological",
"toxicity",
"related",
"to",
"prior",
"therapy",
"must",
"either",
"have",
"returned",
"to",
"=",
"<",
"grade",
"3",
",",
"baseline",
",",
"or",
"deemed",
"irreversible"
] |
[
0,
0,
0,
0,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02101736
|
1:17:chronic_disease,39:48:treatment,,89:104:treatment
|
Active infection requiring systematic treatment within 28 days before the first dose of study treatment
| 1
|
[
"Active",
"infection",
"requiring",
"systematic",
"treatment",
"within",
"28",
"days",
"before",
"the",
"first",
"dose",
"of",
"study",
"treatment"
] |
[
2,
2,
0,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0,
1,
1
] |
NCT02184520
|
1:24:chronic_disease,33:51:chronic_disease,53:76:chronic_disease,78:107:chronic_disease
|
Neuromuscular disorders such as muscular dystrophy, spinal muscular atrophy, amyotrophic lateral sclerosis, etc
| 1
|
[
"Neuromuscular",
"disorders",
"such",
"as",
"muscular",
"dystrophy",
",",
"spinal",
"muscular",
"atrophy",
",",
"amyotrophic",
"lateral",
"sclerosis",
",",
"etc"
] |
[
2,
2,
0,
0,
2,
2,
0,
2,
2,
2,
0,
2,
2,
2,
0,
0
] |
NCT02789228
|
1:19:chronic_disease,21:48:chronic_disease,59:79:treatment,83:99:chronic_disease
|
Refractory disease, residual detectable disease following conventional therapy or relapsed disease
| 1
|
[
"Refractory",
"disease",
",",
"residual",
"detectable",
"disease",
"following",
"conventional",
"therapy",
"or",
"relapsed",
"disease"
] |
[
2,
2,
0,
2,
2,
2,
0,
1,
1,
0,
2,
2
] |
NCT03093909
|
37:51:treatment,62:74:treatment,76:89:treatment,94:110:treatment
|
Patients receiving other concurrent cancer therapy including chemotherapy, immunotherapy, or biologic therapy
| 1
|
[
"Patients",
"receiving",
"other",
"concurrent",
"cancer",
"therapy",
"including",
"chemotherapy",
",",
"immunotherapy",
",",
"or",
"biologic",
"therapy"
] |
[
0,
0,
0,
0,
1,
1,
0,
1,
0,
1,
0,
0,
1,
1
] |
NCT02624765
|
1:38:chronic_disease,,
|
severe congenital fetal abnormalities (T 13 or 18; surgery or death expected < 1 month)
| 1
|
[
"severe",
"congenital",
"fetal",
"abnormalities",
"(",
"T",
"13",
"or",
"18",
";",
"surgery",
"or",
"death",
"expected",
"<",
"1",
"month",
")"
] |
[
2,
2,
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02985554
|
15:31:chronic_disease,
|
Patients with active infection, un-resolving more than grade 2 transplant-related toxicities
| 1
|
[
"Patients",
"with",
"active",
"infection",
",",
"un-resolving",
"more",
"than",
"grade",
"2",
"transplant-related",
"toxicities"
] |
[
0,
0,
2,
2,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT03085095
|
12:31:treatment
|
History of surgical castration
| 1
|
[
"History",
"of",
"surgical",
"castration"
] |
[
0,
0,
1,
1
] |
NCT02507232
|
1:22:cancer,24:37:cancer,39:67:cancer,72:111:cancer
|
Pilocytic astrocytoma, ganglioglioma, pleomorphic xanthastrocytoma, or dysembryoplastic neuroepithelial tumors
| 1
|
[
"Pilocytic",
"astrocytoma",
",",
"ganglioglioma",
",",
"pleomorphic",
"xanthastrocytoma",
",",
"or",
"dysembryoplastic",
"neuroepithelial",
"tumors"
] |
[
3,
3,
0,
3,
0,
3,
3,
0,
0,
3,
3,
3
] |
NCT03113760
|
32:42:cancer
|
current or previous history of malignancy
| 1
|
[
"current",
"or",
"previous",
"history",
"of",
"malignancy"
] |
[
0,
0,
0,
0,
0,
3
] |
NCT00909909
|
1:26:cancer
|
Invasive ductal carcinoma
| 1
|
[
"Invasive",
"ductal",
"carcinoma"
] |
[
3,
3,
3
] |
NCT02658565
|
23:35:treatment
|
Patients who received chemotherapy directed at the present disease
| 1
|
[
"Patients",
"who",
"received",
"chemotherapy",
"directed",
"at",
"the",
"present",
"disease"
] |
[
0,
0,
0,
1,
0,
0,
0,
0,
0
] |
NCT02838797
|
1:9:chronic_disease
|
diabetes
| 1
|
[
"diabetes"
] |
[
2
] |
NCT02276443
|
18:33:cancer,,78:95:cancer,151:156:cancer,161:196:cancer
|
Prior history of invasive cancer within 5 years of study entry or history of metastatic cancer; exceptions include non-metastatic, curatively treated basal and squamous cell carcinoma of the skin
| 1
|
[
"Prior",
"history",
"of",
"invasive",
"cancer",
"within",
"5",
"years",
"of",
"study",
"entry",
"or",
"history",
"of",
"metastatic",
"cancer",
";",
"exceptions",
"include",
"non-metastatic",
",",
"curatively",
"treated",
"basal",
"and",
"squamous",
"cell",
"carcinoma",
"of",
"the",
"skin"
] |
[
0,
0,
0,
3,
3,
0,
0,
0,
0,
0,
0,
0,
0,
0,
3,
3,
0,
0,
0,
0,
0,
0,
0,
3,
0,
3,
3,
3,
3,
3,
3
] |
NCT02158234
|
1:6:cancer,
|
Tumor within 1 cm of the spinal cord
| 1
|
[
"Tumor",
"within",
"1",
"cm",
"of",
"the",
"spinal",
"cord"
] |
[
3,
0,
0,
0,
0,
0,
0,
0
] |
NCT02819440
|
16:32:treatment
|
Current use of organic nitrates
| 1
|
[
"Current",
"use",
"of",
"organic",
"nitrates"
] |
[
0,
0,
0,
1,
1
] |
NCT02740361
|
9:24:treatment,
|
started pharmacotherapy for depression within the last 2 months
| 1
|
[
"started",
"pharmacotherapy",
"for",
"depression",
"within",
"the",
"last",
"2",
"months"
] |
[
0,
1,
0,
0,
0,
0,
0,
0,
0
] |
NCT03137173
|
1:48:chronic_disease
|
Uncomplicated skin and skin structure infection
| 1
|
[
"Uncomplicated",
"skin",
"and",
"skin",
"structure",
"infection"
] |
[
2,
2,
2,
2,
2,
2
] |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.